Second generation patents in pharmaceutical innovation /
"The development of new medications and improvements thereof are crucial to ensure continued gains in health. The development process is long and costly, mainly to produce the information that meets high regulatory requirements. In contrast, imitation involves negligible costs and much reduced...
Saved in:
| Main Author: | Ahn, Hyewon, (Author) |
|---|---|
| Corporate Author: | Munich Intellectual Property Law Center. |
| Format: | Book |
| Language: | English |
| Published: |
Baden-Baden :
Nomos,
2014.
|
| Edition: | 1. edition. |
| Series: | MIPLC studies ;
v. 19. |
| Subjects: | |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Patentability of chemical selection inventions : the Olanzapine and Escitalopram decisions / Hyewon Ahn.
by: Ahn, Hyewon.
Published: (2011) -
Patenting of pharmaceuticals and impact on availability with reference to cipro shortage / by Anurag K. Agarwal.
by: Agarwal, Anurag K.
Published: (2002) -
Ergänzende Schutzzertifikate = Patent term extensions : USA, Japan, EU, Germany, Korea, Taiwan, Switzerland, Australia, Israel, Russia and Singapore / Arne Markgraf (Hrsg.).
Published: (2015) -
Patent rights in pharmaceuticals in developing countries : major challenges for the future / Jakkrit Kuanpoth.
by: Jakkrit Kuanpoth.
Published: (2010) -
Representational fairness in WTO rule-making : negotiating, implementing, and disputing the TRIPS pharmaceutical-related provisions / Mohamed Omar Gad.
by: Gad, Mohamed Omar.
Published: (2006)


